Sivagurunathan Sutharsan

Also affiliated with University of Duisburg-Essen

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes”.

Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes

New England Journal of Medicine(2021)10.1056/nejmoa2100665

N/A

7.1DataRank · unranked

277 citations

Marcus Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter‐de Groot, Isabelle Fajac +17 more

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00411-9

N/A

1.9DataRank · unranked

95 citations

Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00504-5

N/A

1.5DataRank · unranked

67 citations

Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.08.007

N/A

0.464DataRank · unranked

21 citations

Michael W. Konstan, Jennifer L. Taylor‐Cousar, Isabelle Fajac, Alex Horsley, Sivagurunathan Sutharsan +11 more

Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.06.001

N/A

0DataRank · unranked

33 citations

Sivagurunathan Sutharsan, Ralph Epaud, Ross C. Klingsberg, Rainald Fischer, Steven M. Rowe +7 more

Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective

Respiratory Medicine(2025)10.1016/j.rmed.2025.108076

N/A

0DataRank · unranked

5 citations

K. Hill, Michael Waldron, Barbara Messore, Luca Riberi, Marcus Svedberg +19 more